Stig Anders Jakob Lindberg founded Cellectricon AB. Presently, he is Chief Executive & Scientific Officer at Oncopeptides AB and Deputy Director at Oncopeptides Incentive AB (a subsidiary of Oncopeptides AB) and Chief Executive Officer & Director at Lindberg Life-Science AB.
He is also Deputy Director at Oncopeptides Incentive AB and on the board of 7 other companies.
In his past career he occupied the position of Chief Executive Officer & Director at Cellectricon AB, Consultant at McKinsey & Co., Inc., Analyst at Merrill Lynch & Co., Inc., Deputy Director at Eirus Medical AB and Vice President of Investor Growth Capital AB.
Stig Anders Jakob Lindberg received a doctorate and a graduate degree from Karolinska Institutet and an undergraduate degree from the University of Stockholm.